Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Safety and Efficacy of Intravenous ACZ885 and Oral Methotrexate Therapy in Patients With Early Rheumatoid Arthritis

ClinicalTrials.gov ID: NCT00487825

Public ClinicalTrials.gov record NCT00487825. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 29, 2026, 8:54 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 26-week, Phase II, Multi-center, Randomized, Double-blind, Placebo-controlled Study to Assess the Response to Treatment (ACR50) and to Determine a Biomarker Profile in Responders to ACZ885 (Anti-interleukin-1beta Monoclonal Antibody) Plus MTX as Compared to MTX Alone in Early Rheumatoid Arthritis Patients

Study identification

NCT ID
NCT00487825
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Novartis
Industry
Enrollment
78 participants

Conditions and interventions

Interventions

  • Canakinumab (investigational) Drug
  • Methotrexate (MTX) Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 28, 2007
Primary completion
Nov 30, 2008
Completion
Nov 30, 2008
Last update posted
Jul 31, 2012

2007 – 2008

United States locations

U.S. sites
17
U.S. states
12
U.S. cities
17
Facility City State ZIP Site status
Rheumatology Associates of Northern Alabama (Dr. William Shergy) Huntsville Alabama 35801
Clinic for Rheumatic Diseases (Dr. Richard Jones, III) Tuscaloosa Alabama 35406
Arizona Arthritis and Rheumatology Research (Dr. Paul Caldron) Paradise Valley Arizona 85253
Jacksonville Center for Clinical Research (Dr. Steven Mathews) Jacksonville Florida 32216
Center for Arthritis and Rheumatic Diseases (Dr. Michael Weitz) South Miami Florida 33143
West Broward Rheumatology Associates, Incorporated (Dr. Elias Halpert) Tamarac Florida 33321
Rockford Orthopedic Associates (Dr. Richard Olson) Rockford Illinois 61107
Mercy Arthritis and Osteoporosis Center (Dr. Alan Braun) Urbandale Iowa 50322
Clayton Medical Research (Dr. Iri Don) Richmond Heights Missouri 63117
Westroads Medical Group (Dr. William Palmer) Omaha Nebraska 68114
Arthritis Center of Reno (Dr. Malin Prupas) Reno Nevada 89502
Oklahoma Center for Arthritis therapy and Research (Dr. James McKay) Tulsa Oklahoma 74104
MetaClin Research, Incorporated (Dr. Paul Pickrell) Austin Texas 78704
John M. Joseph, MD (Dr. John Joseph) Carlton Texas 75007
Southwest Rheumatology, P.A. (Dr. Atul Singhal) Mesquite Texas 75150
Arthritis Clinic of Northern Virginia (Dr. Philip Kempf) Arlington Virginia 22205
Arthritis Northwest Rheumatology, PLLC (Dr. Jeffrey Butler) Spokane Washington 99204

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00487825, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 31, 2012 · Synced Apr 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00487825 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →